Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy.

Zhang B, Liu ZH, Zeng CH, Zheng JM, Chen HP, Li LS.

J Nephrol. 2008 Jan-Feb;21(1):110-7. Erratum in: J Nephrol. 2008 May-Jun;21(3):446.

PMID:
18264944
2.

Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.

Zhang B, Liu ZH, Zeng CH, Zheng JM, Chen HP, Zhou H, Li LS.

Chin Med J (Engl). 2005 Apr 5;118(7):555-60.

PMID:
15820086
3.

Lipoprotein glomerulopathy: significance of lipoprotein and ultrastructural features.

Saito T, Oikawa S, Sato H, Sato T, Ito S, Sasaki J.

Kidney Int Suppl. 1999 Jul;71:S37-41.

PMID:
10412734
4.

Lipoprotein glomerulopathy: clinical features and pathological characteristics in Chinese.

Chen HP, Liu ZH, Gong RJ, Tang Z, Zeng CH, Zhu MY, Wang JP, Zhou H, Li LS.

Chin Med J (Engl). 2004 Oct;117(10):1513-7.

PMID:
15498375
5.

Lipoprotein glomerulopathy associated with psoriasis vulgaris: report of 2 cases with apolipoprotein E3/3.

Chang CF, Lin CC, Chen JY, Yang AH, Shiao MS, Kao JT, Yang WC.

Am J Kidney Dis. 2003 Sep;42(3):E18-23.

PMID:
12955707
6.

Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.

Saito T, Matsunaga A, Oikawa S.

Am J Kidney Dis. 2006 Feb;47(2):199-211. Review.

PMID:
16431249
7.

Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy.

Saito T, Ishigaki Y, Oikawa S, Yamamoto TT.

Trends Cardiovasc Med. 2002 Feb;12(2):67-70. Review.

PMID:
11852253
8.

Virus-mediated transduction of apolipoprotein E (ApoE)-sendai develops lipoprotein glomerulopathy in ApoE-deficient mice.

Ishigaki Y, Oikawa S, Suzuki T, Usui S, Magoori K, Kim DH, Suzuki H, Sasaki J, Sasano H, Okazaki M, Toyota T, Saito T, Yamamoto TT.

J Biol Chem. 2000 Oct 6;275(40):31269-73.

9.

A complete genomic analysis of the apolipoprotein E gene in Chinese patients with lipoprotein glomerulopathy.

Chen S, Liu ZH, Zheng JM, Zhang X, Li LS.

J Nephrol. 2007 Sep-Oct;20(5):568-75.

PMID:
17918142
10.

[A 3-amino acid deletion of apolipoprotein E found in 3 Chinese lipoprotein glomerulopathy patients].

Chen YQ, Zhang H, Zhu SL, Zou WZ, Wang M, Liu ZS, Wang HY.

Zhonghua Yi Xue Za Zhi. 2003 May 10;83(9):774-7. Chinese.

PMID:
12899757
11.

A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy.

Bomback AS, Song H, D'Agati VD, Cohen SD, Neal A, Appel GB, Rovin BH.

Nephrol Dial Transplant. 2010 Oct;25(10):3442-6. doi: 10.1093/ndt/gfq389. Epub 2010 Jul 11.

PMID:
20624773
12.

A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.

Mitani A, Ishigami M, Watase K, Minakata T, Yamamura T.

J Atheroscler Thromb. 2011;18(6):531-5. Epub 2011 Feb 16.

13.

Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy.

Luo B, Huang F, Liu Q, Li X, Chen W, Zhou SF, Yu X.

Am J Nephrol. 2008;28(2):347-53. Epub 2007 Nov 29.

14.

[Clinical and pathological analyses of lipoprotein glomerulopathy].

Hu ZX, Zhang XH, Sha ZH, Yang LC, Huang SM.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2004 May;35(3):442-4. Chinese.

PMID:
15181857
15.

Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy.

Hoffmann M, Scharnagl H, Panagiotou E, Banghard W, Wieland H, März W.

J Am Soc Nephrol. 2001 Mar;12(3):524-30.

16.

A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy.

Matsunaga A, Sasaki J, Komatsu T, Kanatsu K, Tsuji E, Moriyama K, Koga T, Arakawa K, Oikawa S, Saito T, Kita T, Doi T.

Kidney Int. 1999 Aug;56(2):421-7.

17.

[Identification of a mutation in exon 4 of apolipoprotein E gene in a family affected with lipoprotein glomerulopathy].

Han HL, Lin S, Sun LS, Zhang P, Zhai DP.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012 Apr;29(2):141-4. doi: 10.3760/cma.j.issn.1003-9406.2012.02.005. Chinese.

PMID:
22487820
18.

Association of genetic variation in apolipoprotein E and low density lipoprotein receptor with ischemic stroke in Northern Han Chinese.

Wang B, Zhao H, Zhou L, Dai X, Wang D, Cao J, Niu W.

J Neurol Sci. 2009 Jan 15;276(1-2):118-22. doi: 10.1016/j.jns.2008.09.013. Epub 2008 Oct 11.

PMID:
18851860
19.

A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy.

Toyota K, Hashimoto T, Ogino D, Matsunaga A, Ito M, Masakane I, Degawa N, Sato H, Shirai S, Umetsu K, Tamiya G, Saito T, Hayasaka K.

J Hum Genet. 2013 May;58(5):254-8. doi: 10.1038/jhg.2013.8. Epub 2013 Feb 14.

PMID:
23407349
20.

Common apolipoprotein E gene mutations contribute to lipoprotein glomerulopathy in China.

Han J, Pan Y, Chen Y, Li X, Xing G, Shi J, Hou P, Zhang H, Wang H.

Nephron Clin Pract. 2010;114(4):c260-7. doi: 10.1159/000276578. Epub 2010 Jan 20.

PMID:
20090368

Supplemental Content

Support Center